The Foundation supports research across basic, translational and clinical science to speed breakthroughs that can lead to the creation of new treatments and a better quality of life for people with Parkinson's disease.
Search or browse funded studies
Previously funded studies appear chronologically, with the most recent appearing first.
-
MJFF Research Grant, 2010Development of an Assay to Detect LRRK2 Protein in Biological Samples
Objective/Rationale:
LRRK2 (Leucine-Rich Repeat Kinase 2) is a protein thought to be involved in regulating signaling pathways in cells. Mutations in the gene for LRRK2 are associated with some... -
MJFF Research Grant, 2010Intranasal GDNF for Parkinson's Disease: Next Steps in Preclinical Development
Objective/Rationale:
GDNF, a “growth factor” capable of promoting the survival of dopamine neurons, has great potential as a treatment for Parkinson’s disease. However, getting GDNF into the brain has... -
LRRK2, 2010The Trondheim LRRK2 Cohort Program
Objective/Rationale:
We are examining a Symptoms & Side Effects family members of LRRK2-PD patients looking for clinical features indicating differences between mutation carriers and non-carriers... -
LRRK2, 2010Genetic and Environmental Modifiers for LRRK2-Associated PD
Objective/Rationale:
In the last decades, mutations of several genes have been found to cause familial Parkinson’s disease (PD) and variants of these genes can also increase the risk for developing... -
MJFF Research Grant, 2010PROGENI Family Study
Objective/Rationale:
The LRRK2 Consortium is designing studies to allow researchers to identify the key genetic, biological and clinical features of LRRK2 associated PD that could lead to improved... -
Alpha-Synuclein Therapeutics, 2010Anti-amyloid Oligomer Monoclonal Antibodies for Treatment of Parkinson's Disease
Objective/Rationale:
The goal of this project is to evaluate the interaction of a panel of conformation dependent, aggregation specific anti-amyloid monoclonal antibodies with alpha-synuclein...
Apply for a Grant
Our funding programs support basic, translational and clinical research from academia and industry.